Business Description
Compare
Compare
Traded in other countries / regions
APE.GermanyADXN.Switzerland0QNV.UKADDXF.USA IPO Date
2020-01-29Description
Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 23.32 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -41.67 | |||||
| Beneish M-Score | -3.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -31 | |||||
| 3-Year EBITDA Growth Rate | -88.9 | |||||
| 3-Year EPS without NRI Growth Rate | -85.9 | |||||
| 3-Year Book Growth Rate | -33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.19 | |||||
| 9-Day RSI | 42.71 | |||||
| 14-Day RSI | 43.76 | |||||
| 6-1 Month Momentum % | 174.3 | |||||
| 12-1 Month Momentum % | -56.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.83 | |||||
| Quick Ratio | 2.83 | |||||
| Cash Ratio | 2.53 | |||||
| Days Sales Outstanding | 81.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.8 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1737.19 | |||||
| Net Margin % | -1759.95 | |||||
| ROE % | -185.88 | |||||
| ROA % | -131.72 | |||||
| ROIC % | -2584.71 | |||||
| ROC (Joel Greenblatt) % | -4424.84 | |||||
| ROCE % | -172.99 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.74 | |||||
| PB Ratio | 1.19 | |||||
| Price-to-Tangible-Book | 1.18 | |||||
| EV-to-EBIT | -0.49 | |||||
| EV-to-EBITDA | -0.5 | |||||
| EV-to-Revenue | 8.61 | |||||
| EV-to-Forward-Revenue | 3.04 | |||||
| EV-to-FCF | -0.65 | |||||
| Price-to-Net-Current-Asset-Value | 1.27 | |||||
| Price-to-Net-Cash | 1.49 | |||||
| Earnings Yield (Greenblatt) % | -204.08 |
How Addex Therapeutics Ltd (ADXN) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ADXN
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.295 | ||
| EPS (TTM) ($) | -3.545 | ||
| Beta | 0 | ||
| Volatility % | 147.8 | ||
| 14-Day RSI | 43.76 | ||
| 14-Day ATR ($) | 0.207547 | ||
| 20-Day SMA ($) | 1.432745 | ||
| 12-1 Month Momentum % | -56.45 | ||
| 52-Week Range ($) | 0.55 - 5.45 | ||
| Shares Outstanding (Mil) | 19.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Addex Therapeutics Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Addex Therapeutics Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Addex Therapeutics Ltd Frequently Asked Questions
What is Addex Therapeutics Ltd(ADXN)'s stock price today?
The current price of ADXN is $1.16. The 52 week high of ADXN is $5.45 and 52 week low is $0.55.
When is next earnings date of Addex Therapeutics Ltd(ADXN)?
The next earnings date of Addex Therapeutics Ltd(ADXN) is 2023-05-05 Est..
Does Addex Therapeutics Ltd(ADXN) pay dividends? If so, how much?
Addex Therapeutics Ltd(ADXN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
